AMGN - AMGEN INC


329.82
-16.430   -4.982%

Share volume: 3,821,061
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.37%

PREVIOUS CLOSE
CHG
CHG%

$346.25
-16.43
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025 03-31-2026
Fiscal Quarter Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Report Date 08-06-2024 10-30-2024 02-14-2025 05-01-2025 08-05-2025 11-04-2025 02-13-2026 04-30-2026
Cash flow financing -2.649 B -3.651 B -1.407 B -4.107 B -2.673 B -2.853 B -1.226 B 1.436 B
Other financing cash flows 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cash flow -407.000 M -290.000 M 2.962 B -3.163 B -782.000 M 1.417 B -316.000 M 2.909 B
Net income 746.000 M 2.830 B 627.000 M 1.730 B 1.432 B 3.216 B 1.333 B 1.819 B
Depreciation 1.400 B 1.396 B 1.397 B 1.387 B 1.341 B 1.307 B 1.132 B 1.116 B
Changes in inventories 0.000 0.000 0.000 -288.000 M 0.000 0.000 0.000 -18.000 M
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -217.000 M -210.000 M -402.000 M -447.000 M -389.000 M -414.000 M -693.000 M -716.000 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 21.000 M 47.000 M -31.000 M -36.000 M -20.000 M 22.000 M 2.000 M -4.000 M
Dividends Paid -1.209 B -1.210 B -1.205 B -1.279 B -1.280 B -1.282 B -1.283 B -1.358 B
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 238.000 M 257.000 M 371.000 M 411.000 M 369.000 M 436.000 M 642.000 M 712.000 M
Cash Change -407.000 M -290.000 M 2.962 B -3.163 B -782.000 M 1.417 B -316.000 M 2.909 B